BGHL (EUR): NAV(s)  

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
102
BGHL (EUR): NAV(s)

 

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

 

Close of business 10 Jul 2017.

 

Estimated NAV

 

  Euro Shares Sterling Shares
Estimated NAV €  23.6867 £  20.8460
Estimated MTD return  -0.27 %  -0.27 %
Estimated YTD return  6.96 %  7.23 %
Estimated ITD return  136.87 %  108.46 %

 

NAV and returns are calculated net of management and performance fees

 

Market information

 

Euro Shares Amsterdam (AEX) London (LSE)
Market Close €  19.62 N/A
Premium/discount to estimated NAV  -17.17 % N/A
     
Sterling Shares Amsterdam (AEX) London (LSE)
Market Close N/A GBX 1,655.00
Premium/discount to estimated NAV N/A  -20.61 %

 

 

Transactions in own securities purchased into treasury

 

Ordinary Shares Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A
Range of Price N/A N/A

           

                                           

Liquidity Enhancement Agreement Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A

 

BGHL Capital

 

BGHL Ordinary Shares Euro Shares Sterling Shares
Shares Outstanding  28,862,115  528,912
Held in treasury N/A N/A
Shares Issued  28,862,115  528,912

 

Estimated BG Fund NAV

Class B Euro Shares (estimated) €  187.9844

The Class B Euro Shares of BG Fund are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.

 

For further information please contact:

Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.com

 

The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.

This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.

You should always bear in mind that:

all investment is subject to risk;

results in the past are no guarantee of future results;

the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and

if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice.

 

This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.

 

 

 

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...cd80620dd1

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 111

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 38

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Political Jitters Push US Investors to Golden Visas

Updated Category News Views 118

Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...

Continue Reading
GeneDx Faces Scrutiny: Are Fiduciary Duties at Risk?

Updated Category News Views 71

What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...

Continue Reading
BNY's Conference Spotlight: Strategic Moves Ahead?

Updated Category News Views 119

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 88

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 7

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading

Top 5 Most Recently Viewed Articles

Nvidia's Global Competition at Risk Amid U.S. AI Legislation

Updated Category News Views 393

Nvidia Raises Concerns Over Legislative Changes NVIDIA Corp. (NASDAQ: NVDA) has expressed significant concerns regarding proposed legislation in Congress, which aims to limit its ability to sell chips globally. This comes in the wake of a recent export agreement between President Trump and NVIDIA that allows chip sales to China. The company argues that the new legislative...

Continue Reading
Olin Corporation Insights on Adjusted EBITDA for 2025

Updated Category News Views 209

Olin Corporation Offers Updated Outlook for Fourth Quarter Olin Corporation (NYSE: OLN) has provided insights regarding its performance for the fourth quarter of 2025, indicating a significant deviation from its previous expectations. The latest forecast suggests an adjusted EBITDA of nearly $67 million, a notable decrease from the earlier anticipated range of $110 to...

Continue Reading
Innovature BPO Welcomes Thoai Nguyen as COO to Enhance Operations

Updated Category News Views 134

Raising Standards in Business Process Outsourcing Innovature BPO is making headlines with the recent appointment of Thoai Nguyen as Chief Operating Officer. This strategic decision reflects the company's ambition to enhance its operational effectiveness and continue providing exceptional service in outsourcing. With a commitment to integrating AI-driven solutions,...

Continue Reading
TCL and F-Secure: Innovating Secure Connectivity Together

Updated Category News Views 224

TCL and F-Secure Forge a Strategic Partnership TCL, renowned for its innovations in display technology, has recently proclaimed a robust alliance with F-Secure, a leader in cybersecurity. This strategic collaboration was unveiled during Network X 2025 and aims to bolster the security features in TCL's products across Fixed Broadband (FBB), Fixed Wireless Access (FWA), and...

Continue Reading
Innovative Aromatherapy Fan Enhances Comfort and Relaxation

Updated Category News Views 154

Introduction to the Aromatherapy Accessory In today's fast-paced world, finding ways to unwind and relax is essential for maintaining overall well-being. What if you could enjoy the calming effects of aromatherapy while staying cool? An innovative inventor from Crown Point, Indiana, set out to create a solution that combines the benefits of aromatherapy with the...

Continue Reading